GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Ramsay Generale de Sante SA (XPAR:GDS) » Definitions » EV-to-EBIT

Ramsay Generale dente (XPAR:GDS) EV-to-EBIT : 34.29 (As of May. 29, 2025)


View and export this data going back to 2001. Start your Free Trial

What is Ramsay Generale dente EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Ramsay Generale dente's Enterprise Value is €4,770 Mil. Ramsay Generale dente's EBIT for the trailing twelve months (TTM) ended in Dec. 2024 was €139 Mil. Therefore, Ramsay Generale dente's EV-to-EBIT for today is 34.29.

The historical rank and industry rank for Ramsay Generale dente's EV-to-EBIT or its related term are showing as below:

XPAR:GDS' s EV-to-EBIT Range Over the Past 10 Years
Min: 16.32   Med: 24.94   Max: 43.23
Current: 34.29

During the past 13 years, the highest EV-to-EBIT of Ramsay Generale dente was 43.23. The lowest was 16.32. And the median was 24.94.

XPAR:GDS's EV-to-EBIT is ranked worse than
77.9% of 457 companies
in the Healthcare Providers & Services industry
Industry Median: 16.82 vs XPAR:GDS: 34.29

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Ramsay Generale dente's Enterprise Value for the quarter that ended in Dec. 2024 was €5,170 Mil. Ramsay Generale dente's EBIT for the trailing twelve months (TTM) ended in Dec. 2024 was €139 Mil. Ramsay Generale dente's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2024 was 2.69%.


Ramsay Generale dente EV-to-EBIT Historical Data

The historical data trend for Ramsay Generale dente's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ramsay Generale dente EV-to-EBIT Chart

Ramsay Generale dente Annual Data
Trend Dec14 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 31.04 23.90 21.12 25.04 34.46

Ramsay Generale dente Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 25.04 - 34.46 -

Competitive Comparison of Ramsay Generale dente's EV-to-EBIT

For the Medical Care Facilities subindustry, Ramsay Generale dente's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ramsay Generale dente's EV-to-EBIT Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Ramsay Generale dente's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Ramsay Generale dente's EV-to-EBIT falls into.


;
;

Ramsay Generale dente EV-to-EBIT Calculation

Ramsay Generale dente's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=4769.769/139.1
=34.29

Ramsay Generale dente's current Enterprise Value is €4,770 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Ramsay Generale dente's EBIT for the trailing twelve months (TTM) ended in Dec. 2024 was €139 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ramsay Generale dente  (XPAR:GDS) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Ramsay Generale dente's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2024 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2024 ) =EBIT / Enterprise Value (Q: Dec. 2024 )
=139.1/5170.4612
=2.69 %

Ramsay Generale dente's Enterprise Value for the quarter that ended in Dec. 2024 was €5,170 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Ramsay Generale dente's EBIT for the trailing twelve months (TTM) ended in Dec. 2024 was €139 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ramsay Generale dente EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Ramsay Generale dente's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Ramsay Generale dente Business Description

Traded in Other Exchanges
Address
39 Rue Mstislav, Rostropovitch, Paris, FRA, 75017
Ramsay Generale de Sante SA operates in the private healthcare sector in France. The company provides a comprehensive range of patient care services in thirteen business segments: Nouvelle Aquitaine, Bourgogne-Franche Comte, Brittany, Centre-Val de Loire, Hauts de France, Normandy, Provence Alpes Cote d'Azur, Ile de France, Auvergne-Rhone Alpes, Occitanie, Italy, Nordics, and Head Office. It generates maximum revenue from the Ile de France segment. The company also specializes in cardiology, heart surgery, digestive surgery, dermatology, urology, ophthalmology, vascular and endovascular surgery.